Clearmind Medicine (CMND) Assets Average (2023 - 2026)
Clearmind Medicine (CMND) posted quarterly Assets Average of $12.8 million for Q2 2026, up 118.16% year-over-year from $5.9 million in Q2 2025, and up 49.0% quarter-over-quarter from $8.6 million in Q1 2026.
Clearmind Medicine (CMND) Assets Average (2023 - 2026) Analysis & Trends
Clearmind Medicine's Assets Average history runs 4 years deep, the most recent figure standing at $12.8 million for Q2 2026.
- In Q2 2026, Assets Average rose 118.16% year-over-year to $12.8 million; the TTM figure through Apr 2026 stood at $12.8 million (up 118.16% YoY), while the FY2025 annual figure was $6.7 million, up 0.98% from the prior year.
- Assets Average for Q2 2026 stood at $12.8 million, up from $8.6 million in the prior quarter.
- The five-year high for Assets Average was $12.8 million in Q2 2026, with the low at $2.7 million in Q1 2023.
- The 4-year median for Assets Average is $6.4 million (2025), against an average of $6.9 million.
- The sharpest annual moves came in 2024 and 2025: Assets Average surged 194.16% in 2024, then plunged 46.24% in 2025.
- Clearmind Medicine's Assets Average stood at $5.2 million in 2023, then soared by 47.76% to $7.7 million in 2024, then slumped by 34.85% to $5.0 million in 2025, then surged by 155.33% to $12.8 million in 2026.
- Business Quant data shows CMND's Assets Average at $12.8 million in Q2 2026, $8.6 million in Q1 2026, and $5.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - | 12.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 12.83 Mn |
| Jan 31, 2026 | 8.61 Mn |
| Oct 31, 2025 | 5.03 Mn |
| Jul 31, 2025 | 4.58 Mn |
| Apr 30, 2025 | 5.88 Mn |
| Jan 31, 2025 | 6.92 Mn |
| Oct 31, 2024 | 7.71 Mn |
| Jul 31, 2024 | 8.51 Mn |
| Apr 30, 2024 | 9.47 Mn |
| Jan 31, 2024 | 8.03 Mn |
| Oct 31, 2023 | 5.22 Mn |
| Jul 31, 2023 | 5.24 Mn |
| Apr 30, 2023 | 5.30 Mn |
| Jan 31, 2023 | 2.73 Mn |